JENNIFER BANFIELD: Open Payments
NPI 1265730519 · BOYS TOWN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 50 payments from 10 companies in 2025. Trend: 2023 $598 · 2024 $706 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 26 | $488 |
| Regeneron Healthcare Solutions, Inc. | 8 | $157 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| Pharming Healthcare, Inc. | 1 | $125 |
| CSL Behring | 2 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| BioCryst US Sales Co., LLC | 1 | $35 |
| Amgen Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, FASENRA, Hizentra, NEFFY, ORLADEYO, TEZSPIRE, AIRSUPRA, EBGLYSS.
Industry payments across NE — which companies pay providers there.
